Keenan Greg bought AUPH
February 28, 2025 · Form 4 insider transaction
Keenan Greg bought 62,583 shares of Aurinia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
62,583
Price
$0.00
Total value
N/A
InsiderKeenan Greg
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 28, 2025
Filing dateMarch 4, 2025
Shares owned after174,028
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement.